top of page
MEMORANDUMS OF UNDERSTANDING
DOMESTIC
Offer assistance to the NIH Centers for Accelerated Innovations (NCAI) grantees intending to develop drugs for commercialization with regulatory guidance on technology development.
NIH National Heart, Lung, and Blood Institute (NHLBI)
CDER Norman Stockbridge, MD, PhD (301) 796-2240
2015-02-16
2019-12-31
Collaboration to develop strategic plans, set priorities, and leverage resources and expertise toward facilitating development of nanotechnologies for safer and effective cancer diagnostics and therapies.
National Cancer Institute (NCI), National Institute of Standards and Technology (NIST)
OC Office of the Chief Scientist Frank Weichold, M.D. (301) 975-6759
2015-01-20
2020-01-19
Joint effort by FSIS and FDA to respond to requests for sanctioning the use of food ingredients and sources of radiation intended for use in the products of meat products and poultry products. This MOU was first signed in 2000 and amended in 2015.
USDA Food Safety Inspection Service (FSIS)
CFSAN Dennis Keefe (240) 402-1200
2015-01-15
Indefinite
The purpose of this MOU is to allow FDA/CDRH to offer assistance to the NIH Centers for Accelerated Innovations (NCAI) grantees with the regulatory processes involved in technology development and commercialization.
NIH National Heart, Lung, and Blood Institute (NHLBI)
CDRH Murry Sheldon, MD (301) 797-5443
2015-01-15
Indefinite
Establishes the framework for collaboration on women's health initiatives between two components of the Department of Health and Human Services (DHHS): The Food and Drug Administration (FDA), Office Women's Health (OWH) and the National Institutes of Health (NIH), Office of Research on Women's Health(ORWH).FDA OWH and NIH ORWH share common priorities and interests in promoting awareness and understanding of the science of sex-based differences.
NIH Office of Research on Women's Health (ORWH)
OC OWH Deborah Kallgren (301) 796-9442
2014-12-10
2019-12-09
Promote scientific progress through the exchange of scientific capital in a Cardiovascular Disease Drug Development Fellowship Training and Research Program.
National Capital Consortium
CDER Karen Hickman, M.D. (301) 796-1089
2014-10-17
2019-10-16
Information sharing on food safety pesticide data in an electronic formation including pesticide labeling, maximum residue levels (MRLs) and research activities substantiality affecting the public health.
Environmental Protection Agency (EPA)
CFSAN Randy Levin
2014-09-10
Indefinite
Framework for cooperation between FDA and FSIS/USDA for regulation of Siluriformes fish and fish products re 2014 Farm Bill.
USDA Food Safety Inspection Service (FSIS)
CFSAN (240) 402-1729
2014-04-30
Indefinite
Work to promote a health information technology (IT) framework that promotes innovation, protects patient safety, and avoids regulatory duplication
Office of the National Coordinator for Health Information Technology (ONC), Federal Communications Commission (FCC)
CDRH Bakul Patel (301) 796-5528
2014-04-22
Indefinite
To establish the framework between FDA and USAID for testing the ability of the Counterfeit Detection Device to identify counterfeit drugs, including falsified products and substandard anti-malarial drugs in Ghana
U.S. Agency for International Development
OIP Leigh Verbois
2014-04-21
Indefinite
Establishes a framework to promote efficiency and collaboration between FDA and PHEMCE Partners to meet common needs for considering issues related to safety, efficacy, and utilization of drugs, biologics, and medical devices for use in emergencies, including response preparedness and planning.
HHS, DoD, DHS, DVA, USDA
OC Luciana Borio MD (301) 796-8510
2014-03-11
Indefinite
Establishes a framework and procedures to enhance collaborations and exchange of information.
NCI Center to Reduce Cancer Health Disparities (CRCHD)
OWH Brent Howard (301) 796-1409
2014-01-02
Indefinite
bottom of page